Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.72
Bid: 9.73
Ask: 10.18
Change: -0.195 (-1.97%)
Spread: 0.45 (4.625%)
Open: 9.72
High: 9.72
Low: 9.72
Prev. Close: 9.915
BVA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2021 MREL Requirement

1 Jun 2021 07:00

RNS Number : 3047A
Banco Bilbao Vizcaya Argentaria SA
01 June 2021
 

 

 

 

Banco Bilbao Vizcaya Argentaria, S.A. ("BBVA"), in compliance with the Securities Market legislation, hereby communicates the following:

INSIDE INFORMATION

BBVA has received a new communication from the Bank of Spain regarding its minimum requirement for own funds and eligible liabilities ("MREL"), as determined by the Single Resolution Board ("SRB"), that has been calculated taking into account the financial and supervisory information as of December 31, 2019[1], and which supersedes the previous MREL communication published on November 19, 2019.

In accordance with this new MREL communication, BBVA has to reach, by January 1, 2022, an amount of own funds and eligible liabilities equal to 24.78%[2] of the total risk weighted assets ("RWAs") of its resolution group, on sub-consolidated level[3] (the "MREL in RWAs"). Within this MREL in RWAs, an amount equal to 13.50%2 of the RWAs shall be met with subordinated instruments (the "subordination requirement in RWA").

This MREL in RWA is equal to 10.25% in terms of the total exposure considered for calculating the leverage ratio (the "MREL in LR"), while the subordination requirement in RWAs is equal to 5.84% in terms of the total exposure considered for calculating the leverage ratio (the "subordination requirement in LR").

The current own funds and eligible liabilities structure of the resolution group meets the MREL in RWAs, the MREL in LR, the subordination requirement in RWAs and the subordination requirement in LR.

 

MREL

 

% RWAs

% Leverage ratio (LR) exposure

Requirement as of January 1, 2022

24.78%

10.25%

Own funds and eligible liabilities as of March 31, 2021

29.23%[4]

13.40%

 

Subordination requirement

 

% RWAs

% Leverage ratio (LR) exposure

Requirement as of January 1, 2022

13.50%

5.84%

Own funds and eligible subordinated liabilities as of March 31, 2021

25.95%4

11.89%

 

 

Madrid, May 31, 2021

 

[1] As the reference date used for the calibration of the MREL has been December 31, 2019, the effects, among other issues, of the expected sale of the BBVA Group subsidiary BBVA USA Bancshares, Inc, which was announced to the market on November 16, 2020, have not been taken into account.

[2] In accordance with the new applicable regulation, the MREL in RWAs and the subordination requirement in RWAs do not include the combined capital buffer requirement. For these purposes, the applicable combined capital buffer requirement would be 2.5%, without prejudice to any other buffer that may be applicable at any time.

[3] Pursuant to BBVA Group's MPE (Multiple Point of Entry) resolution strategy, as established by the SRB, the resolution group consists of Banco Bilbao Vizcaya Argentaria S.A. and the subsidiaries that belong to the same European resolution group. As of December 31, 2019, the RWAs of the resolution group amounted to 204,218 million euros and the total exposure considered for calculating the leverage ratio amounted to 422,376 million euros.

[4] Own funds and eligible liabilities to meet both MREL in RWAs or subordination requirement in RWAs, as applicable, and the combined capital buffer requirement, which would be 2.5%, without prejudice to any other buffer that may apply at any time.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUAUKRAWUVOAR
Date   Source Headline
29th Apr 201411:16 amRNSPublication of Financial Statements
24th Apr 20145:24 pmRNSResults of BBVA for 1Q 2014 will be presented
14th Apr 20145:14 pmRNSDividend Option
4th Apr 20145:43 pmRNSInformation of Prudential Relevance
26th Mar 20145:49 pmRNSDividend Option
14th Mar 20145:29 pmRNSDividend option
14th Mar 20145:18 pmRNSRESOLUTION PASSED
4th Mar 20142:09 pmRNSMoody's has today upgraded BBVA's ratings
12th Feb 20147:00 amRNSPerpetual contingent convertible securities
7th Feb 20144:54 pmRNSRemuneration policy of the BBVA board of directors
7th Feb 20144:49 pmRNS2013 Annual Corporate Governance Report
7th Feb 20144:29 pmRNSProposed resolutions and the director's report
31st Jan 20148:55 amRNSResults year 2013: Analysts presentation
31st Jan 20147:44 amRNSPress release and group information 2013
31st Jan 20147:00 amRNSAGM Statement
27th Jan 20145:11 pmRNSResults of BBVA for 4Q 2013 will be presented
27th Jan 20147:00 amRNSAccount reclassification
20th Dec 20137:00 amRNSSale in PANAMA
20th Dec 20137:00 amRNSCORPBANCA
5th Nov 201311:05 amRNSDividend option: Capital increase
25th Oct 20139:03 amRNSAnalysts presentation: 3rd Quarter Results
25th Oct 20137:22 amRNS3rd Quarter: Press release and group information
21st Oct 20135:39 pmRNSBBVA results for 3Q 2013 will be presented
21st Oct 20131:07 pmRNSCNCB's PARTIAL SALE
17th Oct 20139:03 amRNSCNCB's PARTIAL SALE (Information)
17th Oct 20137:01 amRNSCNCB's PARTIAL SALE
14th Oct 20136:10 pmRNSDividend option
2nd Oct 20137:51 amRNSBBVA completes the sale of AFP Provida- Chile
25th Sep 20136:17 pmRNSAppointment in the executive committee
25th Sep 20135:04 pmRNSDividend option
13th Sep 20135:29 pmRNS"Dividend Option"
12th Sep 20139:05 amRNSInvestment plan for South America in 2013 - 2016
26th Jul 20135:13 pmRNSPresentation of the results for 2Q13
22nd Jul 20137:00 amRNSAgreement for the sale of BBVA Panama
16th Jul 20134:24 pmRNSApplication for admission new ordinary shares
4th Jul 201311:20 amRNSOffering Circular - Replacement
3rd Jul 20135:40 pmRNSConvertible Bonds
3rd Jul 20131:06 pmRNSSupplement to the Offering Circular
28th Jun 20136:26 pmRNSConvertible Bonds
24th Jun 20135:09 pmRNSFirst interim dividend against 2013 results
21st Jun 20137:51 amRNSConvertible bonds
12th Jun 20136:20 pmRNSClauses limiting the interest rate
6th Jun 20135:43 pmRNSStabilisation Notice
30th May 20137:00 amRNSAppointment new executive director of BBVA
24th May 20137:00 amRNSPayment of interests
23rd May 20136:06 pmRNSUnnim Banc S.A., merger by absorption
21st May 20135:21 pmRNSCONVERTIBLE BONDS
14th May 20133:59 pmRNSCapital increase
30th Apr 20135:57 pmRNSIssue securities
29th Apr 20133:20 pmRNSStabilisation Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.